Wall Street Experts
ver. ZuMIgo(08/25)
Aileron Therapeutics, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -30
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
Rok finansowy |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Przychód (mln) |
22 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Przychód Δ r/r |
0.0% |
-100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Marża brutto |
45.3% |
-inf% |
0.0% |
0.0% |
0.0% |
0.0% |
-inf% |
-inf% |
-inf% |
-inf% |
-inf% |
EBIT (mln) |
3 |
-16 |
-13 |
-18 |
-23 |
-32 |
-30 |
-20 |
-27 |
-28 |
-16 |
EBIT Δ r/r |
0.0% |
-588.2% |
-19.6% |
40.9% |
26.6% |
38.7% |
-6.1% |
-31.6% |
29.8% |
3.9% |
-41.1% |
EBIT (%) |
14.7% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-0 |
0 |
EBITDA (mln) |
4 |
-15 |
-13 |
-18 |
-23 |
-32 |
-30 |
-20 |
-27 |
-27 |
-16 |
EBITDA(%) |
18.2% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Podatek (mln) |
3 |
0 |
0 |
0 |
0 |
0 |
-1 |
1 |
-0 |
-0 |
0 |
Zysk Netto (mln) |
0 |
-16 |
-13 |
-18 |
-23 |
-32 |
-29 |
-22 |
-26 |
-27 |
-16 |
Zysk netto Δ r/r |
0.0% |
-8382.0% |
-19.8% |
40.7% |
24.7% |
39.6% |
-8.8% |
-24.2% |
18.1% |
4.8% |
-41.8% |
Zysk netto (%) |
0.9% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
EPS |
10.21 |
-845.63 |
-23.6 |
-33.21 |
-60.74 |
-42.81 |
-23.46 |
-12.52 |
-5.8 |
-5.95 |
-3.42 |
EPS (rozwodnione) |
10.85 |
-844.96 |
-23.6 |
-33.21 |
-60.74 |
-42.81 |
-23.46 |
-12.52 |
-5.8 |
-5.95 |
-3.42 |
Ilośc akcji (mln) |
0 |
0 |
1 |
1 |
0 |
1 |
1 |
2 |
4 |
5 |
5 |
Ważona ilośc akcji (mln) |
0 |
0 |
1 |
1 |
0 |
1 |
1 |
2 |
4 |
5 |
5 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |